| Covasim: an agent-based model of COVID-19 dynamics and interventions CC Kerr, RM Stuart, D Mistry, RG Abeysuriya, K Rosenfeld, GR Hart, ... PLOS Computational Biology 17 (7), e1009149, 2021 | 656 | 2021 |
| Potential effects of disruption to HIV programmes in sub-Saharan Africa caused by COVID-19: results from multiple mathematical models BL Jewell, E Mudimu, J Stover, D Ten Brink, AN Phillips, JA Smith, ... The lancet HIV 7 (9), e629-e640, 2020 | 430 | 2020 |
| Examining caesarean section rates in Canada using the Robson classification system S Kelly, A Sprague, DB Fell, P Murphy, N Aelicks, Y Guo, J Fahey, ... Journal of Obstetrics and Gynaecology Canada 35 (3), 206-214, 2013 | 191 | 2013 |
| HNF-1α G319S, a transactivation-deficient mutant, is associated with altered dynamics of diabetes onset in an Oji-Cree community BL Triggs-Raine, RD Kirkpatrick, SL Kelly, LD Norquay, PA Cattini, ... Proceedings of the National Academy of Sciences 99 (7), 4614-4619, 2002 | 134 | 2002 |
| Factors associated with increased rates of caesarean section in women of advanced maternal age G Janoudi, S Kelly, A Yasseen, H Hamam, F Moretti, M Walker Journal of Obstetrics and Gynaecology Canada 37 (6), 517-526, 2015 | 95 | 2015 |
| Modeling the epidemiological impact of the UNAIDS 2025 targets to end AIDS as a public health threat by 2030 J Stover, R Glaubius, Y Teng, S Kelly, T Brown, TB Hallett, P Revill, ... PLoS Medicine 18 (10), e1003831, 2021 | 63 | 2021 |
| Impact of vaccination and non-pharmaceutical interventions on SARS-CoV-2 dynamics in Switzerland AJ Shattock, EA Le Rutte, RP Dünner, S Sen, SL Kelly, N Chitnis, ... Epidemics 38, 100535, 2022 | 59 | 2022 |
| The global Optima HIV allocative efficiency model: targeting resources in efforts to end AIDS SL Kelly, R Martin-Hughes, RM Stuart, XF Yap, DJ Kedziora, ... The lancet HIV 5 (4), e190-e198, 2018 | 52 | 2018 |
| Measuring quality in maternal-newborn care: developing a clinical dashboard AE Sprague, SI Dunn, DB Fell, JA Harrold, MC Walker, S Kelly, GN Smith Journal of Obstetrics and Gynaecology Canada 35 (1), 29-38, 2013 | 42 | 2013 |
| The risks and benefits of providing HIV services during the COVID-19 pandemic J Stover, SL Kelly, E Mudimu, D Green, T Smith, I Taramusi, ... Plos one 16 (12), e0260820, 2021 | 37 | 2021 |
| Achieving 90-90-90 human immunodeficiency virus (HIV) targets will not be enough to achieve the HIV incidence reduction target in Australia N Scott, M Stoové, SL Kelly, DP Wilson, ME Hellard Clinical Infectious Diseases 66 (7), 1019-1023, 2018 | 36 | 2018 |
| How should HIV resources be allocated? Lessons learnt from applying Optima HIV in 23 countries RM Stuart, L Grobicki, H Haghparast‐Bidgoli, J Panovska‐Griffiths, ... Journal of the International AIDS Society 21 (4), e25097, 2018 | 35 | 2018 |
| A tale of two countries: progress towards UNAIDS 90‐90‐90 targets in Botswana and Australia T Marukutira, M Stoové, S Lockman, LA Mills, T Gaolathe, R Lebelonyane, ... African Journal of Reproduction and Gynaecological Endoscopy 21 (3), 2018 | 34 | 2018 |
| N-Acetylsphingosine stimulates phosphatidylglycerolphosphate synthase activity in H9c2 cardiac cells FY XU, SL KELLY, GM HATCH Biochemical Journal 337 (3), 483-490, 1999 | 33 | 1999 |
| The impact and cost-effectiveness of combined HIV prevention scenarios among transgender women sex-workers in Lima, Peru: a mathematical modelling study A Bórquez, JV Guanira, P Revill, P Caballero, A Silva-Santisteban, S Kelly, ... The Lancet Public Health 4 (3), e127-e136, 2019 | 32 | 2019 |
| HIV cascade monitoring and simple modeling reveal potential for reductions in HIV incidence SL Kelly, DP Wilson JAIDS Journal of Acquired Immune Deficiency Syndromes 69 (3), 257-263, 2015 | 32 | 2015 |
| Cost-effectiveness of easy-access, risk-informed oral pre-exposure prophylaxis in HIV epidemics in sub-Saharan Africa: a modelling study AN Phillips, A Bershteyn, P Revill, L Bansi-Matharu, K Kripke, MC Boily, ... The Lancet HIV 9 (5), e353-e362, 2022 | 31 | 2022 |
| COVID-19 vaccine booster strategies in light of emerging viral variants: frequency, timing, and target groups SL Kelly, EA Le Rutte, M Richter, MA Penny, AJ Shattock Infectious diseases and therapy 11 (5), 2045-2061, 2022 | 22 | 2022 |
| Modelling the impact of Omicron and emerging variants on SARS-CoV-2 transmission and public health burden EA Le Rutte, AJ Shattock, N Chitnis, SL Kelly, MA Penny Communications Medicine 2 (1), 93, 2022 | 22 | 2022 |
| Costs and impact on HIV transmission of a switch from a criminalisation to a public health approach to injecting drug use in eastern Europe and central Asia: a modelling analysis Z Ward, J Stone, C Bishop, V Ivakin, K Eritsyan, A Deryabina, A Low, ... The Lancet HIV 9 (1), e42-e53, 2022 | 21 | 2022 |
David WilsonUniversity of New South Wales, Burnet Institute, Bill and Melinda Gates Foundation, QueenslandGeverifieerd e-mailadres voor burnet.edu.au
